Gene · 409
Papers2,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Central obesity is detrimental to anti-inflammatory, phenotype, and exhaustion markers in mononuclear cells - A cross-sectional study. | Clin Nutr ESPEN | 2023 | 38057032 | PubTator, text mining | PubMed |
| Distinct beta-arrestin coupling and intracellular trafficking of metabotropic glutamate receptor homo- and heterodimers. | Sci Adv | 2023 | 38055809 | PubTator, text mining | PubMed |
| Structure, function and drug discovery of GPCR signaling. | Mol Biomed | 2023 | 38047990 | PubTator, text mining | PubMed |
| Distinct activation mechanisms of β-arrestin-1 revealed by 19F NMR spectroscopy. | Nat Commun | 2023 | 38030602 | PubTator, text mining | PubMed |
| Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs. | Front Endocrinol (Lausanne) | 2023 | 38027178 | PubTator, text mining | PubMed |
| Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis. | J Pharm Anal | 2023 | 38024852 | PubTator, text mining | PubMed |
| Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients. | Front Immunol | 2023 | 38022584 | PubTator, text mining | PubMed |
| β-Arrestin2 promotes docetaxel resistance of castration-resistant prostate cancer via promoting hnRNP A1-mediated PKM2 alternative splicing. | Discov Oncol | 2023 | 38019357 | PubTator, text mining | PubMed |
| An Overview of Recent Developments in the Management of Burn Injuries. | Int J Mol Sci | 2023 | 38003548 | PubTator, text mining | PubMed |
| Semi-synthetic nanobody-ligand conjugates exhibit tunable signaling properties and enhanced transcriptional outputs at neurokinin receptor-1. | bioRxiv | 2023 | 37986858 | PubTator, text mining | PubMed |
| From Fruit Waste to Medical Insight: The Comprehensive Role of Watermelon Rind Extract on Renal Adenocarcinoma Cellular and Transcriptomic Dynamics. | Int J Mol Sci | 2023 | 37958599 | PubTator, text mining | PubMed |
| Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial. | Open Forum Infect Dis | 2023 | 37942459 | PubTator, text mining | PubMed |
| Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy. | Bioinformatics | 2023 | 37930015 | PubTator, text mining | PubMed |
| The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice. | Front Mol Biosci | 2023 | 37900918 | PubTator, text mining | PubMed |
| Research progress on the roles of neurovascular unit in stroke-induced immunosuppression. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37899404 | PubTator, text mining | PubMed |
| GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function. | Cell Rep | 2023 | 37897727 | PubTator, text mining | PubMed |
| Network-Derived Radioresistant Breast Cancer Target with Candidate Inhibitors from Brown Algae: A Sequential Assessment from Target Selection to Quantum Chemical Calculation. | Mar Drugs | 2023 | 37888480 | PubTator, text mining | PubMed |
| Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies. | Biology (Basel) | 2023 | 37887031 | PubTator, text mining | PubMed |
| β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor. | Elife | 2023 | 37855711 | PubTator, text mining | PubMed |
| Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors. | Cell | 2023 | 37852260 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/409/papers?page=6